Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Myocardial injury after major non-cardiac surgery evaluated with advanced cardiac imaging, a pilot study

  • Álvarez-Garcia, Jesús
  • Popova, Ekaterine|||0000-0002-8781-9873
  • Vives-Borrás, Miquel|||0000-0002-5345-4124
  • Nadal Clanchet, Miriam de|||0000-0002-4559-2463
  • Ordóñez, J. (Jordi)|||0000-0003-4896-5832
  • Rivas-Lasarte, Mercedes|||0000-0002-8704-3104
  • Moustafa, Abdel Hakim|||0000-0001-6077-6888
  • Solé González, Eduard|||0000-0002-5727-9925
  • Paniagua, Pilar|||0000-0002-0215-1561
  • Garcia-Moll, Xavier|||0000-0001-7837-8378
  • Viladés Medel, David|||0000-0002-3638-9703
  • Leta, Rubén|||0000-0003-4691-381X
  • Oristrell, Gerard|||0000-0003-3217-987X
  • Zamora, Javier|||0000-0003-4901-588X
  • Ferreira-Gonzalez, Ignacio|||0000-0002-1208-5561
  • Alonso-Coello, Pablo|||0000-0002-8001-8504
  • Carreras Costa, Francesc|||0000-0002-1944-0562
Background: Myocardial injury after non-cardiac surgery (MINS) is a frequent complication caused by cardiac and non-cardiac pathophysiological mechanisms, but often it is subclinical. MINS is associated with increased morbidity and mortality, justifying the need to its diagnose and the investigation of their causes for its potential prevention. Methods: Prospective, observational, pilot study, aiming to detect MINS, its relationship with silent coronary artery disease and its effect on future adverse outcomes in patients undergoing major non-cardiac surgery and without postoperative signs or symptoms of myocardial ischemia. MINS was defined by a high-sensitive cardiac troponin T (hs-cTnT) concentration.
Repisalud
Publication Artículo científico (JournalArticle)

A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.

  • Escala-Garcia, Maria
  • Abraham, Jean
  • Andrulis, Irene L
  • Anton-Culver, Hoda
  • Arndt, Volker
  • Ashworth, Alan
  • Auer, Paul L
  • Auvinen, Päivi
  • Beckmann, Matthias W
  • Beesley, Jonathan
  • Behrens, Sabine
  • Benitez, Javier
  • Bermisheva, Marina
  • Blomqvist, Carl
  • Blot, William
  • Bogdanova, Natalia V
  • Bojesen, Stig E
  • Bolla, Manjeet K
  • Børresen-Dale, Anne-Lise
  • Brauch, Hiltrud
  • Brenner, Hermann
  • Brucker, Sara Y
  • Burwinkel, Barbara
  • Caldas, Carlos
  • Canzian, Federico
  • Chang-Claude, Jenny
  • Chanock, Stephen J
  • Chin, Suet-Feung
  • Clarke, Christine L
  • Couch, Fergus J
  • Cox, Angela
  • Cross, Simon S
  • Czene, Kamila
  • Daly, Mary B
  • Dennis, Joe
  • Devilee, Peter
  • Dunn, Janet A
  • Dunning, Alison M
  • Dwek, Miriam
  • Earl, Helena M
  • Eccles, Diana M
  • Eliassen, A Heather
  • Ellberg, Carolina
  • Evans, D Gareth
  • Fasching, Peter A
  • Figueroa, Jonine
  • Flyger, Henrik
  • Gago-Dominguez, Manuela
  • Gapstur, Susan M
  • García-Closas, Montserrat
  • García-Sáenz, José A
  • Gaudet, Mia M
  • George, Angela
  • Giles, Graham G
  • Goldgar, David E
  • González-Neira, Anna
  • Grip, Mervi
  • Guénel, Pascal
  • Guo, Qi
  • Haiman, Christopher A
  • Håkansson, Niclas
  • Hamann, Ute
  • Harrington, Patricia A
  • Hiller, Louise
  • Hooning, Maartje J
  • Hopper, John L
  • Howell, Anthony
  • Huang, Chiun-Sheng
  • Huang, Guanmengqian
  • Hunter, David J
  • Jakubowska, Anna
  • John, Esther M
  • Kaaks, Rudolf
  • Kapoor, Pooja Middha
  • Keeman, Renske
  • Kitahara, Cari M
  • Kraft, Peter
  • Lambrechts, Diether
  • Le Marchand, Loic
  • Lejbkowicz, Flavio
  • Lindblom, Annika
  • Lubiński, Jan
  • Mannermaa, Arto
  • Manoochehri, Mehdi
  • Manoukian, Siranoush
  • Margolin, Sara
  • Martinez, Maria Elena
  • Maurer, Tabea
  • Mavroudis, Dimitrios
  • Meindl, Alfons
  • Milne, Roger L
  • Mulligan, Anna Marie
  • Neuhausen, Susan L
  • Nevanlinna, Heli
  • Newman, William G
  • Olshan, Andrew F
  • Olson, Janet E
  • Olsson, Håkan
  • Orr, Nick
  • Peterlongo, Paolo
  • Petridis, Christos
  • Prentice, Ross L
  • Presneau, Nadege
  • Punie, Kevin
  • Ramachandran, Dhanya
  • Rennert, Gad
  • Romero, Atocha
  • Sachchithananthan, Mythily
  • Saloustros, Emmanouil
  • Sawyer, Elinor J
  • Schmutzler, Rita K
  • Schwentner, Lukas
  • Scott, Christopher
  • Simard, Jacques
  • Sohn, Christof
  • Southey, Melissa C
  • Swerdlow, Anthony J
  • Tamimi, Rulla M
  • Tapper, William J
  • Teixeira, Manuel R
  • Terry, Mary Beth
  • Thorne, Heather
  • Tollenaar, Rob A E M
  • Tomlinson, Ian
  • Troester, Melissa A
  • Truong, Thérèse
  • Turnbull, Clare
  • Vachon, Celine M
  • van der Kolk, Lizet E
  • Wang, Qin
  • Winqvist, Robert
  • Wolk, Alicja
  • Yang, Xiaohong R
  • Ziogas, Argyrios
  • Pharoah, Paul D P
  • Hall, Per
  • Wessels, Lodewyk F A
  • Chenevix-Trench, Georgia
  • Bader, Gary D
  • Dörk, Thilo
  • Easton, Douglas F
  • Canisius, Sander
  • Schmidt, Marjanka K
  • Gonzalez Neira, Anna
  • Andrulis, Irene L.
  • Auer, Paul L.
  • Beckmann, Matthias W.
  • Bogdanova, Natalia V.
  • Bojesen, Stig E.
  • Bolla, Manjeet K.
  • Brucker, Sara Y.
  • Chanock, Stephen J.
  • Clarke, Christine L.
  • Couch, Fergus J.
  • Cross, Simon S.
  • Daly, Mary B.
  • Dunn, Janet A.
  • Dunning, Alison M.
  • Earl, Helena M.
  • Eccles, Diana M.
  • Eliassen, A. Heather
  • Evans, D. Gareth
  • Fasching, Peter A.
  • Gapstur, Susan M.
  • García-Sáenz, José A.
  • Gaudet, Mia M.
  • Giles, Graham G.
  • Goldgar, David E.
  • Haiman, Christopher A.
  • Harrington, Patricia A.
  • Hooning, Maartje J.
  • Hopper, John L.
  • Hunter, David J.
  • John, Esther M.
  • Kitahara, Cari M.
  • Koppert, Linetta B
  • Kristensen, Vessela N
  • Milne, Roger L.
  • Neuhausen, Susan L.
  • Newman, William G.
  • Olshan, Andrew F.
  • Olson, Janet E.
  • Prentice, Ross L.
  • Sawyer, Elinor J.
  • Schmutzler, Rita K.
  • Southey, Melissa C.
  • Swerdlow, Anthony J.
  • Tamimi, Rulla M.
  • Tapper, William J.
  • Tollenaar, Rob A. E. M.
  • Troester, Melissa A.
  • Vachon, Celine M.
  • van der Kolk, Lizet E.
  • Yang, Xiaohong R.
  • Pharoah, Paul D. P.
  • Wessels, Lodewyk F. A.
  • Bader, Gary D.
  • Easton, Douglas F.
  • Schmidt, Marjanka K.
Identifying the underlying genetic drivers of the heritability of breast cancer prognosis remains elusive. We adapt a network-based approach to handle underpowered complex datasets to provide new insights into the potential function of germline variants in breast cancer prognosis. This network-based analysis studies ~7.3 million variants in 84,457 breast cancer patients in relation to breast cancer survival and confirms the results on 12,381 independent patients. Aggregating the prognostic effects of genetic variants across multiple genes, we identify four gene modules associated with survival in estrogen receptor (ER)-negative and one in ER-positive disease. The modules show biological enrichment for cancer-related processes such as G-alpha signaling, circadian clock, angiogenesis, and Rho-GTPases in apoptosis.
DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

In Vitro and In Vivo Antimicrobial Activity of Hypochlorous Acid against Drug-Resistant and Biofilm-Producing Strains

  • Palau Gauthier, Marta
  • Muñoz, Estela
  • Lujan, Enric
  • Larrosa, María Nieves
  • Gomis Rodriguez, Javier
  • Marquez Algaba, Ester
  • Len, Oscar
  • Almirante, Benito
  • Abella, Jordi
  • Colominas, Sergi
  • Gavaldà, Joan
The aims of this study were as follows. First, we determined the antimicrobial efficacy of hypochlorous acid (HClO) against bacterial, fungal, and yeast strains growing planktonically and growing in biofilms. Second, we sought to compare the activity of the combination of daptomycin and HClO versus those of the antimicrobial agents alone for the treatment of experimental catheter-related Staphylococcus epidermidis infection (CRI) using the antibiotic lock technique (ALT) in a rabbit model. HClO was generated through direct electric current (DC) shots at determined amperages and times. For planktonic susceptibility studies, 1 to 3 DC shots of 2, 5, and 10 mA from 0 to 300 s were applied. A DC shot of 20 mA from 0 to 20 min was applied to biofilm-producing strains. Central venous catheters were inserted into New Zealand White rabbits, inoculated with an S. epidermidis strain, and treated with saline solution or ALT using daptomycin (50 mg/mL), HClO (20 mA for 45 min), or daptomycin plus HClO. One hundred percent of the planktonic bacterial, fungal, and yeast strains were killed by applying one DC shot of 2, 5, and 10 mA, respectively. One DC shot of 20 mA for 20 min was sufficient to eradicate 100% of the tested biofilm-producing strains. Daptomycin plus HClO lock therapy showed the highest activity for experimental CRI with S. epidermidis. HClO could be an effective strategy for treating infections caused by extensively drug-resistant or multidrug-resistant and biofilm-producing strains in medical devices and chronic wounds. The results of the ALT using daptomycin plus HClO may be promising., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

In Vitro Antibacterial Activity of Silver Nanoparticles Conjugated with Amikacin and Combined with Hyperthermia against Drug-Resistant and Biofilm-Producing Strains

  • Palau Gauthier, Marta
  • Muñoz, Estela
  • Freixanet Gusta, Muriel
  • Larrosa, María Nieves
  • Gomis, Xavier
  • Gilabert, Joan
  • Almirante, Benito
  • Puntes, Victor
  • Texidó Bartes, Robert
  • Gavaldà, Joan
In view of the current increase and spread of antimicrobial resistance (AMR), there is an urgent need to find new strategies to combat it. This study had two aims. First, we synthesized highly monodispersed silver nanoparticles (AgNPs) of approximately 17 nm, and we functionalized them with mercaptopoly(ethylene glycol) carboxylic acid (mPEG-COOH) and amikacin (AK). Second, we evaluated the antibacterial activity of this treatment (AgNPs_mPEG_AK) alone and in combination with hyperthermia against planktonic and biofilm-growing strains. AgNPs, AgNPs_mPEG, and AgNPs_mPEG_AK were characterized using a suite of spectroscopy and microscopy methods. Susceptibility to these treatments and AK was determined after 24 h and over time against 12 clinical multidrug-resistant (MDR)/extensively drug-resistant (XDR) isolates of Acinetobacter baumannii, Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. The efficacy of the treatments alone and in combination with hyperthermia (1, 2, and 3 pulses at 41°C to 42°C for 15 min) was tested against the same planktonic strains using quantitative culture and against one P. aeruginosa strain growing on silicone disks using confocal laser scanning microscopy. The susceptibility studies showed that AgNPs_mPEG_AK was 10-fold more effective than AK alone, and bactericidal efficacy after 4, 8, 24, or 48 h was observed against 100% of the tested strains. The combination of AgNPs_mPEG_AK and hyperthermia eradicated 75% of the planktonic strains and exhibited significant reductions in biofilm formation by P. aeruginosa in comparison with the other treatments tested, except for AgNPs_mPEG_AK without hyperthermia. In conclusion, the combination of AgNPs_mPEG_AK and hyperthermia may be a promising therapy against MDR/XDR and biofilm-producing strains., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

In Vitro and In Vivo Antimicrobial Activity of Hypochlorous Acid against Drug-Resistant and Biofilm-Producing Strains

  • Palau Gauthier, Marta
  • Muñoz, Estela
  • Lujan, Enric
  • Larrosa, María Nieves
  • Gomis Rodriguez, Javier
  • Marquez Algaba, Ester
  • Len, Oscar
  • Almirante, Benito
  • Abella, Jordi
  • Colominas, Sergi
  • Gavaldà, Joan
The aims of this study were as follows. First, we determined the antimicrobial efficacy of hypochlorous acid (HClO) against bacterial, fungal, and yeast strains growing planktonically and growing in biofilms. Second, we sought to compare the activity of the combination of daptomycin and HClO versus those of the antimicrobial agents alone for the treatment of experimental catheter-related Staphylococcus epidermidis infection (CRI) using the antibiotic lock technique (ALT) in a rabbit model. HClO was generated through direct electric current (DC) shots at determined amperages and times. For planktonic susceptibility studies, 1 to 3 DC shots of 2, 5, and 10 mA from 0 to 300 s were applied. A DC shot of 20 mA from 0 to 20 min was applied to biofilm-producing strains. Central venous catheters were inserted into New Zealand White rabbits, inoculated with an S. epidermidis strain, and treated with saline solution or ALT using daptomycin (50 mg/mL), HClO (20 mA for 45 min), or daptomycin plus HClO. One hundred percent of the planktonic bacterial, fungal, and yeast strains were killed by applying one DC shot of 2, 5, and 10 mA, respectively. One DC shot of 20 mA for 20 min was sufficient to eradicate 100% of the tested biofilm-producing strains. Daptomycin plus HClO lock therapy showed the highest activity for experimental CRI with S. epidermidis. HClO could be an effective strategy for treating infections caused by extensively drug-resistant or multidrug-resistant and biofilm-producing strains in medical devices and chronic wounds. The results of the ALT using daptomycin plus HClO may be promising., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

In Vitro Antibacterial Activity of Silver Nanoparticles Conjugated with Amikacin and Combined with Hyperthermia against Drug-Resistant and Biofilm-Producing Strains

  • Palau Gauthier, Marta
  • Muñoz, Estela
  • Freixanet Gusta, Muriel
  • Larrosa, María Nieves
  • Gomis, Xavier
  • Gilabert, Joan
  • Almirante, Benito
  • Puntes, Victor
  • Texidó Bartes, Robert
  • Gavaldà, Joan
In view of the current increase and spread of antimicrobial resistance (AMR), there is an urgent need to find new strategies to combat it. This study had two aims. First, we synthesized highly monodispersed silver nanoparticles (AgNPs) of approximately 17 nm, and we functionalized them with mercaptopoly(ethylene glycol) carboxylic acid (mPEG-COOH) and amikacin (AK). Second, we evaluated the antibacterial activity of this treatment (AgNPs_mPEG_AK) alone and in combination with hyperthermia against planktonic and biofilm-growing strains. AgNPs, AgNPs_mPEG, and AgNPs_mPEG_AK were characterized using a suite of spectroscopy and microscopy methods. Susceptibility to these treatments and AK was determined after 24 h and over time against 12 clinical multidrug-resistant (MDR)/extensively drug-resistant (XDR) isolates of Acinetobacter baumannii, Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. The efficacy of the treatments alone and in combination with hyperthermia (1, 2, and 3 pulses at 41°C to 42°C for 15 min) was tested against the same planktonic strains using quantitative culture and against one P. aeruginosa strain growing on silicone disks using confocal laser scanning microscopy. The susceptibility studies showed that AgNPs_mPEG_AK was 10-fold more effective than AK alone, and bactericidal efficacy after 4, 8, 24, or 48 h was observed against 100% of the tested strains. The combination of AgNPs_mPEG_AK and hyperthermia eradicated 75% of the planktonic strains and exhibited significant reductions in biofilm formation by P. aeruginosa in comparison with the other treatments tested, except for AgNPs_mPEG_AK without hyperthermia. In conclusion, the combination of AgNPs_mPEG_AK and hyperthermia may be a promising therapy against MDR/XDR and biofilm-producing strains., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

  • Coignard, Juliette
  • Beesley, Jonathan
  • O'Mara, Tracy A.
  • Diez Gibert, Orland
  • Lopez-Fernandez, Adrià
  • Dennis, Joe
  • Tyrer, Jonathan
  • Lush, Michael
Càncer de mama; Genètica del càncer; Factors de risc, Cáncer de mama; Genética del cáncer; Factores de riesgo, Breast cancer; Cancer genetics; Risk factors, Breast cancer (BC) risk for BRCA1 and BRCA2 mutation carriers varies by genetic and familial factors. About 50 common variants have been shown to modify BC risk for mutation carriers. All but three, were identified in general population studies. Other mutation carrier-specific susceptibility variants may exist but studies of mutation carriers have so far been underpowered. We conduct a novel case-only genome-wide association study comparing genotype frequencies between 60,212 general population BC cases and 13,007 cases with BRCA1 or BRCA2 mutations. We identify robust novel associations for 2 variants with BC for BRCA1 and 3 for BRCA2 mutation carriers, P < 10−8, at 5 loci, which are not associated with risk in the general population. They include rs60882887 at 11p11.2 where MADD, SP11 and EIF1, genes previously implicated in BC biology, are predicted as potential targets. These findings will contribute towards customising BC polygenic risk scores for BRCA1 and BRCA2 mutation carriers.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Perrault syndrome with neurological features in a compound heterozygote for two TWNK mutations, Overlap of TWNK-related recessive disorders

  • Domínguez-Ruiz, María
  • García-Martínez, Alberto
  • Corral-Juan, Marc|||0000-0001-9407-7516
  • Pérez-Álvarez, Ángel I.
  • Plasencia, Ana M.
  • Villamar, Manuela
  • Moreno-Pelayo, Miguel Ángel|||0000-0003-3839-5098
  • Matilla-Dueñas, Antoni|||0000-0002-3514-4181
  • Mendez-Gonzalez, Manuel|||0000-0002-5218-0774
  • Del Castillo, Ignacio
Background: Perrault syndrome is a rare autosomal recessive disorder that is characterized by the association of sensorineural hearing impairment and ovarian dysgenesis in females, whereas males have only hearing impairment. In some cases, patients present with a diversity of neurological signs. To date, mutations in six genes are known to cause Perrault syndrome, but they do not explain all clinically-diagnosed cases. In addition, the number of reported cases and the spectra of mutations are still small to establish conclusive genotype-phenotype correlations. Methods: Affected siblings from family SH19, who presented with features that were suggestive of Perrault syndrome, were subjected to audiological, neurological and gynecological examination. The genetic study included genotyping and haplotype analysis for microsatellite markers close to the genes involved in Perrault syndrome, whole-exome sequencing, and Sanger sequencing of the coding region of the TWNK gene. Results: Three siblings from family SH19 shared similar clinical features: childhood-onset bilateral sensorineural hearing impairment, which progressed to profound deafness in the second decade of life; neurological signs (spinocerebellar ataxia, polyneuropathy), with onset in the fourth decade of life in the two females and at age 20 years in the male; gonadal dysfunction with early cessation of menses in the two females. The genetic study revealed two compound heterozygous pathogenic mutations in the TWNK gene in the three affected subjects: c.85C.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

In Vitro Antibacterial Activity of Silver Nanoparticles Conjugated with Amikacin and Combined with Hyperthermia against Drug-Resistant and Biofilm-Producing Strains

  • Palau Gauthier, Marta|||0000-0002-4567-9868
  • Muñoz, Estela|||0000-0002-6693-4987
  • Freixanet Gustà, Muriel|||0000-0001-9872-3079
  • Larrosa, María Nieves|||0000-0001-8808-0233
  • Gomis, Xavier
  • Gilabert, Joan|||0000-0002-8718-1312
  • Almirante Gragera, Benito|||0000-0002-1189-2361
  • Puntes, Víctor|||0000-0001-8996-9499
  • Texidó, Robert
  • Gavaldà, Joan|||0000-0002-9829-3141
In view of the current increase and spread of antimicrobial resistance (AMR), there is an urgent need to find new strategies to combat it. This study had two aims. First, we synthesized highly monodispersed silver nanoparticles (AgNPs) of approximately 17 nm, and we functionalized them with mercaptopoly(ethylene glycol) carboxylic acid (mPEG-COOH) and amikacin (AK). Second, we evaluated the antibacterial activity of this treatment (AgNPs_mPEG_AK) alone and in combination with hyperthermia against planktonic and biofilm-growing strains. AgNPs, AgNPs_mPEG, and AgNPs_mPEG_AK were characterized using a suite of spectroscopy and microscopy methods. Susceptibility to these treatments and AK was determined after 24 h and over time against 12 clinical multidrug-resistant (MDR)/extensively drug-resistant (XDR) isolates of , , , and . The efficacy of the treatments alone and in combination with hyperthermia (1, 2, and 3 pulses at 41°C to 42°C for 15 min) was tested against the same planktonic strains using quantitative culture and against one strain growing on silicone disks using confocal laser scanning microscopy. The susceptibility studies showed that AgNPs_mPEG_AK was 10-fold more effective than AK alone, and bactericidal efficacy after 4, 8, 24, or 48 h was observed against 100% of the tested strains. The combination of AgNPs_mPEG_AK and hyperthermia eradicated 75% of the planktonic strains and exhibited significant reductions in biofilm formation by in comparison with the other treatments tested, except for AgNPs_mPEG_AK without hyperthermia. In conclusion, the combination of AgNPs_mPEG_AK and hyperthermia may be a promising therapy against MDR/XDR and biofilm-producing strains. IMPORTANCE Antimicrobial resistance (AMR) is one of the greatest public health challenges, accounting for 1.27 million deaths worldwide in 2019. Biofilms, a complex microbial community, directly contribute to increased AMR. Therefore, new strategies are urgently required to combat infections caused by AMR and biofilm-producing strains. Silver nanoparticles (AgNPs) exhibit antimicrobial activity and can be functionalized with antibiotics. Although AgNPs are very promising, their effectiveness in complex biological environments still falls below the concentrations at which AgNPs are stable in terms of aggregation. Thus, improving the antibacterial effectiveness of AgNPs by functionalizing them with antibiotics may be a significant change to consolidate AgNPs as an alternative to antibiotics. It has been reported that hyperthermia has a large effect on the growth of planktonic and biofilm-producing strains. Therefore, we propose a new strategy based on AgNPs functionalized with amikacin and combined with hyperthermia (41°C to 42°C) to treat AMR and biofilm-related infections.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

  • Coignard, Juliette
  • Beesley, Jonathan
  • O'Mara, Tracy A.
  • Diez Gibert, Orland
  • Lopez Fernandez, Adrià
  • Dennis, Joe
  • Tyrer, Jonathan
  • Lush, Michael
Càncer de mama; Genètica del càncer; Factors de risc, Cáncer de mama; Genética del cáncer; Factores de riesgo, Breast cancer; Cancer genetics; Risk factors, Breast cancer (BC) risk for BRCA1 and BRCA2 mutation carriers varies by genetic and familial factors. About 50 common variants have been shown to modify BC risk for mutation carriers. All but three, were identified in general population studies. Other mutation carrier-specific susceptibility variants may exist but studies of mutation carriers have so far been underpowered. We conduct a novel case-only genome-wide association study comparing genotype frequencies between 60,212 general population BC cases and 13,007 cases with BRCA1 or BRCA2 mutations. We identify robust novel associations for 2 variants with BC for BRCA1 and 3 for BRCA2 mutation carriers, P < 10−8, at 5 loci, which are not associated with risk in the general population. They include rs60882887 at 11p11.2 where MADD, SP11 and EIF1, genes previously implicated in BC biology, are predicted as potential targets. These findings will contribute towards customising BC polygenic risk scores for BRCA1 and BRCA2 mutation carriers.